Ruffner Katherine L 4
4 · Cardiff Oncology, Inc. · Filed Jul 14, 2021
Insider Transaction Report
Form 4
Ruffner Katherine L
Chief Medical Officer
Transactions
- Award
Stock Options
2021-07-12+200,000→ 200,000 totalExercise: $6.55Exp: 2031-07-12→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]25% vest on 7/12/2022. The remainder vest in equal installments monthly for 36 months beginning on 8/12/2022 through 7/12/2025.